Ledger.Open graph →
SEC Form D · filed March 22, 2024

Chrysalis Biotherapeutics, Inc

Offering
$3.0M
Sold
$515K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
GALVESTON, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Jeffery Sheldon · Galveston, TXDirectorLauri Sower · Galveston, TXExecDarrell Carney · Galveston, TXExec · DirectorTimothy Schmidt · New York, NYDirectorJames Ryaby · Galveston, TXDirectorMarie Robb · Galveston, TXDirectorLauri Sower · Galveston, TXExecDarrell Carney · Galveston, TXExec · DirectorTimothy Schmidt · Galveston, TXDirectorJames Ryaby · Galveston, TXDirectorMarie Robb · Galveston, TXDirectorJeffery Sheldon · Galveston, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗